Clinical Trial Update: Cardio-protective Effect of Metformin in Patients Undergoing PCI [Phase 3]

View source ↗

Summary

Phase 3 trial investigating whether metformin provides cardio-protective effects in patients undergoing percutaneous coronary intervention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease
• Ischemic Reperfusion Injury

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Future University in Egypt | Conditions: Elective Percutaneous Coronary Intervention, Ischemic Reperfusion Injury | Phase 3 | Status: UNKNOWN